AstraZeneca To Decarbonize U.S. Footprint by Turning Cow Manure Into Renewable Natural Gas
In a first for the pharma sector, AstraZeneca is partnering with Vanguard Renewables to use farm-sourced renewable natural gas to power all U.S. drug-manufacturing sites by the end of 2026
Pharmaceutical giant AstraZeneca will tap renewable natural gas made from cow manure and food waste to sharply reduce its carbon footprint at U.S. operations starting now and over the next few years, the company announced Tuesday.